MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Harvard Bioscience Company Profile (NASDAQ:HBIO)

Consensus Ratings for Harvard Bioscience (NASDAQ:HBIO) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.00 (104.78% upside)

Analysts' Ratings History for Harvard Bioscience (NASDAQ:HBIO)
Show:
DateFirmActionRatingPrice TargetActions
10/30/2015Benchmark Co.Lower Price TargetBuy$8.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2014Alere FinancialInitiated CoverageBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for Harvard Bioscience (NASDAQ:HBIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
5/12/2016Q1$0.02$0.05$26.00 million$27.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2016Q4$0.03$0.03ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315$0.05$0.03$27.01 million$25.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215$0.04$0.05$26.60 million$28.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q414$0.05$0.01$27.15 million$25.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q314$0.09$0.10$29.30 million$30.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q214$0.06$0.06$25.46 million$25.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q2$0.05$0.05ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114$0.03$0.05$26.10 million$25.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413($0.02)$0.05$28.20 million$27.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2013Q313$0.01$0.05$26.10 million$25.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013$0.08$28.30 million$26.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312$0.08$26.40 million$26.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Harvard Bioscience (NASDAQ:HBIO)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Harvard Bioscience (NASDAQ:HBIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Harvard Bioscience (NASDAQ:HBIO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/10/2015Jeffrey DucheminCEOBuy10,000$3.37$33,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015George UvegesDirectorBuy3,000$3.32$9,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2015Robert E GagnonCFOBuy3,000$3.08$9,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2015Jeffrey DucheminCEOBuy2,000$4.41$8,820.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015John F KennedyDirectorBuy2,000$4.33$8,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2015David GreenDirectorSell17,103$5.26$89,961.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2015David GreenDirectorSell51,597$5.28$272,432.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/23/2015David GreenDirectorSell118,500$6.03$714,555.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/22/2015David GreenDirectorSell123,997$6.23$772,501.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/17/2015David GreenDirectorSell42,503$6.55$278,394.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2015David GreenDirectorSell80,168$6.61$529,910.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015David GreenDirectorSell48,712$5.25$255,738.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/30/2014David GreenDirectorSell16,173$5.25$84,908.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/29/2014David GreenDirectorSell100,167$5.25$525,876.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2014David GreenDirectorSell80,202$5.02$402,614.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2014David GreenDirectorSell10,000$4.95$49,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014David GreenDirectorSell117,654$4.97$584,740.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Robert E GagnonCFOBuy5,000$3.86$19,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2014Neal J HarteDirectorSell12,317$3.82$47,050.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2014David GreenDirectorSell27,540$4.47$123,103.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2014David GreenDirectorSell66,090$4.48$296,083.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/3/2014David GreenDirectorSell63,501$4.63$294,009.63View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2013Chane GrazianoMajor ShareholderBuy60,000$5.00$300,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Harvard Bioscience (NASDAQ:HBIO)
DateHeadline
06/27/16 03:16 PMHARVARD BIOSCIENCE INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/02/16 07:07 AMBroker Watchlist: Harvard Bioscience, Inc. (HBIO) - Share Trading News - Broker Watchlist: Harvard Bioscience, Inc. (HBIO)Share Trading News11/26/2013 – Harvard Bioscience, Inc. was upgraded to “buy” by analysts at Sidoti. The share price of Harvard Bioscience, Inc. (HBIO) was up +4.93% during the last trading session, with a day high of 3.88. 134701 shares were traded on Harvard ...Insiders Are Gradually Buying Harvard Bioscience Inc. (NASDAQ:HBIO)HNNall 2 news articles »
05/31/16 05:42 AMHarvard Bioscience to Attend The Benchmark Company, LLC One-on-One Conference in Milwaukee, Wisconsin on June 2, 2016 - [at noodls] - HOLLISTON, Mass., May 31, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will participate ...
05/30/16 08:58 PMNext Weeks Broker Price Targets For Harvard Bioscience, Inc. (HBIO) - Share Trading News - Next Weeks Broker Price Targets For Harvard Bioscience, Inc. (HBIO)Share Trading NewsHarvard Bioscience, Inc. has a 50 day moving average of 3.05 and a 200 day moving average of 3.01. The stock's market capitalization is 120.60M, it has a 52-week low of 2.41 and a 52-week high of 6.10. The share price of the company (HBIO) was up ...
05/29/16 12:52 PMPerformance at a Glance on Harvard Bioscience Inc. (NASDAQ:HBIO) - HNN - Performance at a Glance on Harvard Bioscience Inc. (NASDAQ:HBIO)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how Harvard Bioscience Inc. (NASDAQ:HBIO)'s stock has performed at various points in its past. Currently ...
05/27/16 03:11 PMHARVARD BIOSCIENCE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi -
05/13/16 11:16 AMHarvard Bioscience, Inc. :HBIO-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/12/16 09:50 AMEdited Transcript of HBIO earnings conference call or presentation 12-May-16 12:30pm GMT -
05/12/16 07:30 AMQ4 2015 and Q1 2016 Harvard Bioscience Inc Earnings Call scheduled for 8:30 am ET today -
05/12/16 06:07 AMQ1 2016 Harvard Bioscience Inc Earnings Release - Before Market Open -
05/12/16 05:27 AMHarvard Bioscience Reports First Quarter 2016 Financial Results - [at noodls] - HOLLISTON, Mass., May 12, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the 'Company'), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, ...
05/12/16 05:24 AMHARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex -
05/12/16 05:15 AMHarvard Bioscience reports 1Q loss -
05/04/16 03:20 PMHarvard Bioscience Regains Compliance with NASDAQ's Continued Listing Requirements - [at noodls] - HOLLISTON, Mass., May 04, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the 'Company'), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, ...
05/04/16 03:15 PMHarvard Bioscience Regains Compliance with NASDAQ’s Continued Listing Requirements - [GlobeNewswire] - HOLLISTON, Mass., May 04, 2016-- Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced today that it received written ...
04/29/16 04:42 PMHarvard Bioscience Reports Fourth Quarter And Year-End 2015 Results, Preliminary First Quarter 2016 Revenues And 2016 Financial Guidance - Conference Call to Discuss 2015 and First Quarter 2016 Results to be Held on May 12, 2016 at 8:30 AM ET HOLLISTON, Mass., April 29, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and ...
04/29/16 04:07 PMHarvard Bioscience reports 4Q loss -
03/28/16 05:55 PMHarvard Bioscience to delay 10-K filing, reports Preliminary Q4 revenue -
02/26/16 12:00 PMHarvard Bioscience: 1 Analysts Continue to rate NASDAQ:HBIO - Hints News Network - Harvard Bioscience: 1 Analysts Continue to rate NASDAQ:HBIOHints News NetworkBenchmark Co. initiated coverage on Harvard Bioscience, Inc. (NASDAQ:HBIO). on Jul 28th, 2015. Alere Financial initiated coverage on Harvard Bioscience, Inc. (NASDAQ:HBIO). on Jul 24th, 2014. Janney Montgomery Scott initiated coverage on Harvard ...
02/26/16 12:00 PMCould Harvard Bioscience, Inc. Rise Even More? The Stock Had Another Big Increase Today - RiversideGazette.com - Could Harvard Bioscience, Inc. Rise Even More? The Stock Had Another Big Increase TodayRiversideGazette.comThe stock of Harvard Bioscience, Inc. (NASDAQ:HBIO) is a huge mover today! The stock increased 4.84% or $0.12 during the last trading session, hitting $2.6. About 54,511 shares traded hands. Harvard Bioscience, Inc. (NASDAQ:HBIO) has declined 50.89% ...Harvard Bioscience Incorporated (NASDAQ:HBIO) Shorted Shares Increased By 6.13%Stock Callerall 2 news articles »
02/26/16 12:00 PMEarnings Per Share Preview for Harvard Bioscience, Inc. (HBIO) - RiversideGazette.com - Earnings Per Share Preview for Harvard Bioscience, Inc. (HBIO)RiversideGazette.comWall Street await Harvard Bioscience, Inc. (NASDAQ:HBIO) to release earnings on February, 25. Analysts forecast EPS of $0.03, down exactly $0.05 or 62.50% from 2014's $0.08 EPS. The expected HBIO's profit could reach $1.02M giving the stock 20.67 P/E ...
02/05/16 01:42 PMWhy Heartland Advisors Inc Reported Big Harvard Bioscience Inc Position? - fdanewsalert.com - Why Heartland Advisors Inc Reported Big Harvard Bioscience Inc Position?fdanewsalert.comAnalysts await Harvard Bioscience, Inc. (NASDAQ:HBIO) to reports earnings on February, 25. They expect $0.03 earnings per share, down 62.50% or $0.05 from last year's $0.08 per share. HBIO's profit will be $1.04M for 25.00 P/E if the $0.03 EPS becomes ...
02/03/16 01:04 PMRecent Broker Updates On Harvard Bioscience, Inc. (HBIO) - Risers & Fallers - Recent Broker Updates On Harvard Bioscience, Inc. (HBIO)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Harvard Bioscience, Inc. (HBIO). The latest broker reports which are currently outstanding on Wednesday 3rd February state 2 analysts have a rating of “strong buy”, 0 ...
01/26/16 01:01 PMLatest Analysts Reports On Harvard Bioscience, Inc. (HBIO) - Risers & Fallers - Latest Analysts Reports On Harvard Bioscience, Inc. (HBIO)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Harvard Bioscience, Inc. (HBIO). The latest broker reports which have been released state 2 analysts have a rating of “buy”, 0 analysts “outperform”, 0 analysts “hold”, ...
12/08/15 12:17 PMHARVARD BIOSCIENCE INC Financials -
11/25/15 07:31 AMFalling Earnings Estimates Signal Weakness Ahead for Harvard Bioscience (HBIO) -
11/13/15 08:20 AMStrong Revenue Growth in the $6 Billion Biological Sample Preparation Market - [Accesswire] - REDONDO BEACH, CA / ACCESSWIRE / November 13, 2015 / Biological sample preparation may sound like a commoditized industry, but the $6 billion market serving 500,000 scientists across 80,000 research labs ...
11/05/15 04:58 PMHARVARD BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report -
10/29/15 08:58 AMEdited Transcript of HBIO earnings conference call or presentation 29-Oct-15 12:30pm GMT -
10/29/15 07:30 AMHarvard Bioscience Inc Earnings Call scheduled for 8:30 am ET today -
10/29/15 06:17 AMHARVARD BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Costs Associated with Exit -
10/29/15 06:07 AMQ3 2015 Harvard Bioscience Inc Earnings Release - Before Market Open -
10/29/15 06:03 AMHarvard Bioscience reports 3Q loss -
10/29/15 05:58 AMHarvard Bioscience Reports Third Quarter 2015 Financial Results and Updates Outlook for Full-Year 2015 - [at noodls] - HOLLISTON, Mass., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported ...
About Harvard Bioscience

Harvard Bioscience logoHarvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of specialized products, apparatus and scientific instruments. The Company's products are used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories across the world. The Company's core product range is organized into five product families: Fluidics, Lab Equipment and Supplies, Molecular Analysis, Cell Physiology and Animal Physiology. Its products include instruments, consumables, and systems that are made up of several individual products. The Company's brands include Harvard Apparatus, KD Scientific, Denville Scientific, AHN, Hoefer, Biochrom, BTX, Warner Instruments, MCS, HEKA, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, TBSI and CMA Microdialysis. The Company has sales and manufacturing operations in the United States, the United Kingdom, Germany, Sweden, Spain, France, Canada and China.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: HBIO
  • CUSIP: 41690610
Key Metrics:
  • Previous Close: $2.93
  • 50 Day Moving Average: $3.36
  • 200 Day Moving Average: $3.07
  • P/E Ratio: N/A
  • P/E Growth: 1.93
  • Market Cap: $99.82M
  • Current Quarter EPS Consensus Estimate: $0.18 EPS
Additional Links:
Harvard Bioscience (NASDAQ:HBIO) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha